← back
CVE-2023-42666

Exposure of Sensitive Information to an Unauthorized Actor in DEXMA DEXGate

CVSS 5.3 MEDIUMEPSS 0.4%CWE-200
Vexday Risk Score
13Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 5.3EPSS 0.4%KEV nãoPoC Nuclei Metasploit Patch
Lifecycle
19 Oct 2023Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Affected products
DEXMA · DexGate

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →